Welcome to our dedicated page for eXoZymes SEC filings (Ticker: EXOZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The eXoZymes Inc. (EXOZ) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. eXoZymes is a Nevada corporation with common stock listed on the Nasdaq Capital Market under the ticker EXOZ, as noted in its Form 8-K reports. Through these filings, the company furnishes information about material events related to its AI-enhanced, cell-free biomanufacturing platform and associated programs.
Recent Form 8-K filings have attached press releases and investor presentations that describe key developments in eXoZymes’ business. These include a press release on the 100-fold scale-up of N-trans-caffeoyltyramine (NCT) production using its exozyme-based platform, with reported conversion levels of over 99% from feedstock to product, and investor materials related to its NCTx business. Other 8-Ks have provided updated investor presentations that outline the company’s focus on exozymes, cell-free biomanufacturing, and highly valuable natural product molecules.
On Stock Titan, investors can review these EXOZ filings alongside AI-powered summaries that explain the context and main points of each document. Real-time updates from the SEC’s EDGAR system help surface new 8-Ks and other forms as they are filed, while AI-generated overviews aim to make complex disclosures easier to understand.
For those tracking eXoZymes, the filings page is a way to see how the company formally reports material events such as technical milestones, investor communications, and business updates tied to its biomanufacturing platform. Users can also look for additional forms, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 when they are available, with AI tools helping to highlight important information within these documents.
eXoZymes Inc. filed a current report to make public an updated Investor Presentation as of September 30, 2025. The company, which is listed on the Nasdaq Capital Market under the symbol EXOZ, is using this report to formally furnish the latest version of its presentation to investors and analysts.
The presentation is included as Exhibit 99.1 and is described as an Investor Presentation of eXoZymes Inc. as of September 30, 2025. No new financial results, transactions, or other specific operating updates are detailed in the text of this report itself.